Events & Ideas

September 10-12, 2023 | Bellevue, WA Jack Henningfield will be attending and participating in a panel discussion. VIEW CONFERENCE Discussion: Symposium 6: The Tightrope of Substance Abuse Potential: The Preclinical & Clinical Factors that Make or Break the Scheduling of a Substance, Using Kratom (Mitragyna Speciosa) as an Example 2 – The Current Regulatory 8-Factor… Read More

September 27-28, 2023 | Rockville, MD Jack Henningfield, Judy Ashworth, and Ryan Lanier will be attending. VIEW CONFERENCE

August 3-5, 2023 | Washington, DC Caitlyn Durgin will be attending. VIEW CONFERENCE Poster: Within-subject Comparison of Inter-individual Variations in Opioid-induced Effects

Durgin C, Huhn A, Bergeria C, Finan P, Campbell C, Antoine D, Dunn K. Inter-individual differences in sensitivity to opioids may explain different opioid risk profiles, but to date has only been evaluated in persons with opioid use disorder (OUD). This study examined individual differences in opioid effects within an opioid-naïve population. To be presented… Read More

Durgin C, Huhn A, Bergeria C, Finan P, Campbell C, Antoine D, Dunn K. Only a percentage of people exposed to opioids develop problematic use. Individual opioid sensitivity may explain different opioid risk profiles, but to date has only been evaluated in persons with opioid use disorder (OUD). This study examined how opioid sensitivity manifests… Read More

June 19-23, 2023 | Denver, CO Jack Henningfield and Ryan Lanier will be attending. VIEW CONFERENCE

Moline ML, Cheng JY, Durgin C, Pype S, Buchhalter A, Henningfield J To identify differences and similarities in real-world abuse potential between dual orexin receptor antagonists (DORAs) and other drugs used as hypnotics, either Schedule IV (CIV) or unscheduled. DORAs, the newest hypnotic class, were placed in CIV based largely on human abuse potential (HAP)… Read More

June 17-21, 2023 | Denver, CO Judy Ashworth, Jack Henningfield, August Buchhalter, Ryan Lanier and Caitlyn Durgin will be attending. VIEW CONFERENCE WEBSITE Posters: Within-Subject Variations in Opioid Sensitivity Across Patient-reported Outcomes, Observer-Ratings, Physiological Endpoints, and Analgesic Responses A Novel 3 mg Naloxone Nasal Spray for the Over-the-Counter Market Abuse Potential Similarities Between Hypnotic Classes:… Read More